Brief: Pacific Biosciences of California Q3 Adjusted EPS USD -0.27 Vs. IBES Estimate USD -0.33
30/10/2023 20:03
Oct 30 (Reuters) - Pacific Biosciences of California Q3 EPS USD -0.26. * Q3 adjusted net income USD -67.9 million * Q3 adjusted gross margin 32% * Q3 revenue USD 55.7 million vs. IBES estimate USD 48.8 million * Q3 adjusted gross profit USD 18.1 million
Recent news on Pacific Biosciences of California
See all newsBrief: Pacbio And Verily Health Announce Multi-Year Strategic Collaboration
Pacific Biosciences of California, Inc. reports results for the quarter ended June 30 - Earnings Summary
Pacific Biosciences Q2 adj. loss bigger than estimates on margin pressure
Brief: Pacific Biosciences of California Q2 EPS USD -0.14
Pacific Biosciences of California Inc expected to post a loss of 13 cents a share - Earnings Preview